Safety profile of immune checkpoint inhibitors according to cancer type
CONCLUSION: Ipilimumab and history of autoimmune disease were both associated with the presence of grade≥2 irAEs and grade≥2 irAEs-free survival. The different cancer groups were not.PMID:37225616 | DOI:10.1016/j.bulcan.2023.04.011
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Chlo é Guérin Mathieu Laramas Fran çois Bettega Alexis Bocquet Elodie Berton Maxime Lugosi Laurence Bouillet Anne-Claire Toffart Source Type: research